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Amplex Red is a fluorescent probe that is widely used to detect hydrogen peroxide (H2O2) in a reaction
where it is oxidised to resorufin by horseradish peroxidase (HRP) as a catalyst. This assay is highly rated
amongst other similar probes thanks to its superior sensitivity and stability. However, we report here
that Amplex Red is readily converted to resorufin by a carboxylesterase without requiring H2O2,
horseradish peroxidase or oxygen: this reaction is seen in various tissue samples such as liver and kidney
as well as in cultured cells, causing a serious distortion of H2O2 measurements. The reaction can be
inhibited by Phenylmethyl sulfonyl fluoride (PMSF) at concentrations which do not disturb mitochon-
drial function nor the ability of the Amplex Red-HRP system to detect H2O2. In vitro experiments and in
silico docking simulations indicate that carboxylesterases 1 and 2 recognise Amplex Red with the same
kinetics as carboxylesterase-containing mitochondria. We propose two different approaches to correct
for this problem and re-evaluate the commonly performed experimental procedure for the detection of
H2O2 release from isolated liver mitochondria. Our results call for a serious re-examination of previous
data.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Reactive oxygen species (ROS) are fundamentally involved in
aerobic life. They are generated within biological systems and play
critical roles in most of them. For instance, there is a wealth of
evidence showing that, by causing damage to macromolecules,
ROS can contribute to aging processes and to the pathogenesis of
multiple diseases [1]. However, they also participate in cell dif-
ferentiation, tissue regeneration and cellular signalling processes
that can activate a multitude of stress responses, which may
support survival (review, [2]). Mitochondria play a central role in
cell metabolism and are a major source of ROS in cells [3,4], and
are thus involved in many different physiological and pathological
processes [5,6]. Therefore, there is a substantial need for simple
but reliable and precise techniques to measure mitochondrial ROS
production. Probes that change their fluorescence when oxidizedInc. This is an open access article u
ute for Ageing, Campus for
upon Tyne NE4 5PL, UK.
linicki).provide convenient, sensitive, and versatile means for detecting
ROS. Many probes with similar function have been used, such as
scopoletin [7], p-hydroxyphenylacetate [8], and homovanillic acid
[9]. However, Amplex Red (N-acetyl-3,7-dihydroxyphenoxazine,
AR) offers greater sensitivity, lower background and better stabi-
lity of the resultant fluorescent product, resorufin (7-hydroxy-3H-
phenoxazin-3-one) and is thus preferred [10–15] and has been
critically evaluated [16]. AR (AH2) is oxidised to the highly fluor-
escent resorufin (A) by hydrogen peroxide (H2O2) in a 2-electron
oxidation reaction catalysed by horseradish peroxidase (HRP), re-
sulting in a 1:1 overall stoichiometry:
HRP þ H2O2- Compound I
Compound I þ AH2- Compound II þ AH*
Compound II þ AH2- HRPþ AH* þ 2H2O
AH* þ AH* - A þ AH2nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Although H2O2- and HRP-independent oxidation of AR to re-
sorufin has been described (e.g. by nitric oxide and superoxide
[17]), this occurs at a considerably lower yield than
HRP/H2O2-mediated oxidation. Therefore, in contrast to many
other fluorescent dyes directly oxidised by various types of ROS in
less specific manners [12], the AR method is generally regarded as
allowing full quantification of H2O2 from the resorufin fluores-
cence intensity. Because AR and HRP are widely considered to be
incapable of crossing biological membranes [10] (and manu-
facturers' information), this method is extensively used to quantify
the release of H2O2 from mitochondria, and has been instrumental
to gaining insights into the mechanism of mitochondrial ROS
production [14]. It is also being applied to measure H2O2 release
from cultured cells and tissue homogenates, as well as in various
enzymatic activity assays, as many enzymatic reactions produce
H2O2.
One caveat of the AR assay that has been experimentally ex-
amined is its photosensitivity (reviewed in [18]). However, so far
unresolved problems have been noted when the AR method was
applied to certain tissues. For example, liver mitochondria result in
HRP-independent conversion of AR to resorufin at a high rate even
in the absence of respiratory substrate (i.e. with negligible oxygen
consumption). This results in the raw quantitative values from li-
ver mitochondria being much higher than those from other tissue
mitochondria in similar experimental conditions and with similar
oxygen consumption rates. This phenomenon has been discussed
in the community but no explanation has been put forward so far.
Frequently, it has simply been ignored [15,19–21].
Here we identify carboxylesterase (CES) as an enzyme that
converts AR to resorufin without requiring either oxygen, hydro-
gen peroxide or a peroxidase. We show that contrary to widely
held beliefs, mitochondrial membranes are permeable to AR and
that AR is converted to resorufin by CES in the matrix of mi-
tochondria from tissues with high CES expression. CES can be in-
hibited by Phenylmethyl sulfonyl fluoride (PMSF) at doses that do
not interfere with either mitochondrial function or the kinetics of
the HRP-catalysed oxidation of AR by H2O2. Therefore we propose
protocols for the quantification of H2O2 by the AR method in tis-
sues, cells and mitochondria containing CES. We argue caution in
interpreting previous data using the AR methods in such samples.
Based on our findings, we speculate that drug metabolism may
well be an under-estimated function of mitochondria, especially in
tissues such as liver and kidney.2. Material and methods
2.1. Mice
C57Bl/6 male mice were purchased from Harlan (Blackthorn,
UK). ICRFa are a substrain of C57Bl/6 kept as a long-established
ageing colony at Newcastle [22]. Male mice were housed as de-
scribed [23]. All work complied with the guiding principles for the
care and use of laboratory animals and was licensed by the UK
Home Office (PPL60/3864).
2.2. Mitochondria preparation and subfractionation
Mitochondria from liver, brain and skeletal muscle were iso-
lated as described [24]. Liver mitochondria were then purified
using percoll gradient [24]. For subfractionation of mitochondria,
1 mg of purified mitochondria were gently mixed with 1 ml of
10 mM Tris/HCL, pH 7.4 to obtain mitoplasts and divided into two
aliquots; to one aliquot 2.7 μg proteinase K was added (to shavemitoplasts). Both aliquots were left on ice for 30 min and cen-
trifuged at 12,000g for 10 min at 4 °C. To obtain inner membranes,
100 mM NaCO3 was added to shaved mitoplasts and left on ice for
30 min, and centrifuged at 100,000g for 15 min at 4 °C. Protein
concentration was assessed by BioRad Dc protein assay kit with
BSA as standard.
The specificity of the subfractions was confirmed by western
blots using Apotosis inducing factor (AIF) as a marker for inter-
membrane space, NDUFA9, a subunit of the electron chain trans-
port complex I that is localized in the inner membrane, and glu-
tamate dehydrogenase (GDH), which resides in the mitochondrial
matrix.
2.3. AR assay with mitochondria
H2O2 release by isolated mitochondria was measured in the
assay buffer containing 115 mM KCl, 10 mM KH2PO4, 2 mM MgCl2,
3 mM Hepes, 1 mM EGTA, 0.2% fatty acid free BSA, pH 7.2 at 37 °C,
in the presence of exogenous superoxide dismutase (75 U/ml),
horseradish peroxidase (HRP) (2 U/ml) and Amplex Red (50 mM) at
37 °C. The fluorescent intensity of resorufin, the oxidised product
of AR, was monitored kinetically in a plate reader (FLUOstar
Omega, BMG Labtech) at excitation 544 nm and emission 590 nm.
The experiments were protected from light.
For the experiments to test catalase sensitivity to resorufin, the
concentration of HRP was lowered to 0.05 U/ml in order for cata-
lase to compete for H2O2. Accordingly, the H2O2 generating system
(i.e. the concentration of mitochondria) was also lowered so that it
did not exceed the capacity of H2O2 detection at the given HRP
concentration.
Typically, the basal rate (with mitochondria, no substrates) was
measured for 8–10 min, then respiratory substrates (either Pyr-
uvateþMalate 5 mM or succinate 4 mM) were added to initiate
respiration (and the electron transport chain-linked H2O2 release).
The fluorescent intensities of the experiments were calibrated
against that obtained by the addition of a known amount of H2O2
to the experimental media in the presence of AR and HRP.
As inhibitor of HRP-independent conversion of AR to resorufin,
100 mM PMSF (2 ml of 10 mM PMSF in ethanol to the 200 ml total
volume) was added to the experimental medium immediately
prior to the or during the measurement. Controls received ethanol
only.
In the Homovanillic acid (HVA) assay, AR was replaced with
HVA (4 mM) while all the other experimental conditions remained
identical to the AR assay, and the fluorescent intensity was read at
excitation 310 nm and emission 430 nm.
2.4. AR assays with non-mitochondrial samples
To monitor the conversion of AR to resorufin by different tissue
samples, various organs were washed to remove blood and
homogenized in PBS, and 0.4 mg/ml samples were used in PBS
containing 50 μM AR. The conversion of AR to resorufin by Ces1b
enzyme was monitored in double distilled water. To create anae-
robic conditions, the reaction was carried out in an anaerobic
chamber (Belle Technology, UK), with oxygen concentration
o5 ppm.
2.5. Oxygen consumption measurements
Oxygen consumption rates (OCR) by isolated mitochondria
were measured in a Seahorse XF24 analyzer (Seahorse Bios-
ciences) as described [24], with either 5 mM pyruvate and malate
or 4 mM succinate. The state 3 OCR was achieved by adding 4 mM
ADP, state 4 with 2 μM Oligomycin, and uncoupled rates with
4 μM FCCP. 2.5 μM Antimycin was finally added to inhibit
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The OCR during conversion of AR to resorufin by Ces1b enzyme
was monitored in a high-resolution respirometer, Oxygraph-2k
(Oroboros Instruments).
2.6. Chemicals, enzymes and antibodies
AR was purchased from Life Technologies. All other chemicals
were from Sigma. Carboxylesterase 1 isoform b human was also
from Sigma (E0287); according to the manufacturer, the enzyme
was formulated in 0.1 M Potassium phosphate buffer. The anti-
bodies used in western blot experiments were as follows: NDUFA9
(Abcam, ab14713, 1:1000), AIF (Cell Signalling, #4642, 1:1000),
GDH (gift from Prof. Robert Lightowlers, Newcastle University,
1:500), CES1 (ab45957, 1:1000).
2.7. Microscopy
3D images of purified mitochondria and mitoplasts stained
with AR and mitotracker green (MTG, 100 nm) were acquired
using an LSM510 confocal (Zeiss, Germany) and deconvolved using
Huygens software (SVI, Netherlands). Subsequently, images were
analysed using average line profiles through the central plane of
the stack using ImageJ (http://imagej.nih.gov/ij).
2.8. LCMSMS
20 pmol AR, 20 pmol resorufin standard or 20 pmol of the AR
reaction mixture with CES1b in water were analysed at a flow rate
of 0.5 ml/min using a gradient from 5% B ((A) 0.1% formic acid in
MS grade water, (B) 0.1% formic acid in acetonitrile) to 95% B over
2 min on a Waters Acquity UPLC BFM C18 column (1.7 mM,
2.1 mM50 mM). The eluant was monitored using a Waters Xevo
G2XS QqTOF mass spectrometer operating at a scan frequency of
10 Hz either in MS mode or in MSMS mode scanning for the
precursors 214.0 and 258.0 with a collision energy ramp from 25
to 40 eV. Data were acquired in the range of m/z 50 to m/z 400 at a
resolution of 22,000. Using MassLynx 4.1 extracted ion chroma-
tograms were generated for AR (m/z 258.0766), RT (1.13 min) and
for resorufin (two peaks were observed at m/z 214.0514 with RTs
0.99 min (unchanged averaged peak area over the whole time
course of the experiment) and RT 0.96 min (occurring only afterFig. 1. Liver mitochondria convert AR to resorufin in the absence of respiration or the ca
fluorescent resorufin by equal amounts of mitochondria (0.4 mg/ml) from mouse liver (
indicate the presence of 2 U/ml HRP, while open symbols indicate no HRP in the reaction
(HRP added) or black open circles (no HRP). (b) Average conversion rates of AR to res
tochondria (colours as above) at state 1 (without substrate) and at state 2 (with either c
succinate) in the presence of HRP. Data are mean7SEM, 5 independent experiments
representative kinetic experiment showing resorufin formation in the absence of HRP
abolish membrane potential (red open triangles) or after heat treatment (70° for 30 m
references to colour in this figure legend, the reader is referred to the web version of taddition of CES1b and increasing over time to saturation)). Scans
were averaged across the peaks for each molecule.
2.9. Docking studies
The structures of AR, resorufin and 3,7-dihydroxyphenoxazine
were optimized by using the B3LYP functional and the standard
6-31G(d,p) basis set as implemented in Gamess [25]. Docking si-
mulations involved the resolved CES1 structure in complex with
naloxone methiodide, a heroin analogue (PDB Id: 1MX9) [26] as
well as the already published homology model of CES2 [27]. Al-
though the resolved structure included a homoexameric assembly,
the study was focused on only one CES1 monomer, the structure of
which was prepared by deleting water molecules and all crystal-
lization additives and then underwent a preliminary optimization
maintaining the backbone atoms fixed to preserve the resolved
folding. After deleting the bound substrate, the so optimized
protein structure was utilized by the following docking simula-
tions by using PLANTS which calculates reliable ligand poses by
ant colony optimization algorithm [28]. For both CES isozymes, the
search was focused within a 10 Å radius sphere around the key
serine residue (Ser221 for CES1 and Ser228 for CES2), 20 poses
were generated and scored by ChemPLP function and speed was
set equal to 1. The so obtained best complexes were minimized by
keeping all atoms outside a 10 Å radius sphere around the bound
AR fixed and the optimized complexes were finally used to cal-
culate the parameters required by the predictive equations.3. Results
3.1. Liver mitochondria convert AR into resorufin requiring neither
respiratory chain activity nor HRP
Oxygen consumption by mitochondria at basal rate (state 1, no
exogenous substrate added) is minimal and there is very little
H2O2 generation. Oxygen consumption and H2O2 generation
greatly increase as mitochondria are fuelled with substrate and the
electron transport chain activity increases (state 2). Accordingly,
the rates of AR oxidation by H2O2 to resorufin were close to zero
during state 1 but significantly increased after the addition of
substrate, as seen in kinetic measurements from brain or muscletalyst HRP. (a) Traces of a representative experiment measuring conversion of AR to
red), muscle (green) or brain (blue) in kinetic mode (time course). Closed symbols
mixture. Control reactions without mitochondria are denoted by black filled circles
orufin (normalized to nmol H2O2/min/mg protein) by liver, brain and muscle mi-
omplex I-linked substrate pyruvate and malate (PM) or complex II-linked substrate
. (c) AR conversion to resorufin by liver mitochondria in the absence of HRP. A
by either intact liver mitochondria (red open circles), after a freeze–thaw cycle to
in) to denature mitochondrial proteins (open squares). (For interpretation of the
his article.)
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resorufin was being formed at a high rate even in the absence of
respiratory substrate (state 1) (Fig. 1a and b). In brain or muscle
mitochondria, resorufin formation required HRP as a catalyst, but
in liver mitochondria it occurred in the absence of HRP (Fig. 1a).
Furthermore, this reaction was independent of the intactness of
mitochondria, because it happened even after a freeze–thaw cycle
(Fig. 1c). However, heat denaturation inhibited it (Fig. 1c). The
same results were obtained when fluorescence readings were
made at end-point instead of employing the kinetic mode, ex-
cluding the possibility that artificial photooxidation of AR/resor-
ufin [16,29] was the cause of the HRP-independent oxidation of AR
(data now shown).
3.2. PMSF inhibits the HRP-independent conversion of AR
The addition of PMSF, an inhibitor of serine proteases [30], to
liver mitochondrial preparations completely inhibited the HRP-
independent AR conversion to resorufin (Fig. 2a). This effect was
instantaneous. Importantly, the kinetics of resorufin formation
from PMSF-treated liver mitochondria showed the typical char-
acteristics of mitochondrial H2O2 release [14,31] as seen forFig. 2. PMSF blocks HRP-independent AR conversion. (a) Representative kinetic traces
resorufin in the presence (diamonds) or absence (circles) of 100 mM PMSF. Ethanol (EtO
open symbols indicate no HRP in the reaction mixture. Traces are shown in state 1 (no
rotenone (2.5 mM). In all respiratory states, H2O2 release by PMSF-treated liver mitochon
results. (b) Effects of catalase (CAT) onto AR oxidation by brain (blue) and liver (red) mit
CAT (50 U/ml) and addition of substrate (succinate), PMSF and HRP as indicated. Data are
mitochondria. OCR was measured in a Seahorse XF24 analyzer with 4 mM succinate a
500 mM PMSF. OCRs for basal, state 3 (after ADP), state 4 (after oligomycin) and uncoup
complex I-linked substrate, pyruvateþmalate (5 mM). (For interpretation of the referen
article.)instance in brain mitochondria, namely: (i) resorufin fluorescence
did not increase in non-energized mitochondria, (ii) it increased
with substrate addition, (iii) blocking the electron flow at complex
I by rotenone decreased resorufin fluorescence when a complex II-
linked substrate was used, because rotenone inhibited the reverse-
electron-flow mediated superoxide production by complex I, and
(iv) there was no resorufin fluorescence increase in PMSF-treated
mitochondria when HRP was omitted from the reaction (Fig. 2a).
Moreover, fluorescence from PMSF-treated liver mitochondria also
increased following addition of a complex I-linked substrate. In
this case, addition of rotenone enhanced ROS production from
complex I, and accordingly the rate of fluorescence increased, al-
beit weakly (Supplementary Figure S1; see also Discussion). PMSF
had no effects on resorufin formation from brain mitochondria
under standard experimental conditions where AR was oxidised in
an HRP-dependent manner by H2O2 (Fig. 2a). Adding catalase
(50 U/ml) to the reaction largely inhibited the oxidation of AR by
liver mitochondria in the presence of PMSF and HRP, as in en-
ergized brain mitochondria (Fig. 2b). However, the inhibitory ef-
fect of catalase was diminished in the absence of PMSF and was
completely abolished in the absence of either substrate, HRP or
both (Fig. 2b), indicating that the PMSF-inhibitable, HRP-from liver (red symbols) and brain (blue) mitochondria-induced AR conversion to
H) was added as a control (circles). Closed symbols indicate presence of HRP while
substrate), state 2 (succinate) and after blocking the electron flow at complex I by
dria is very similar to that from brain mitochondria, where PMSF does not affect the
ochondria. Experiments were performed without (filled bars) and with (open bars)
mean7SD, n¼4. (c) PMSF does not affect oxygen consumption rates (OCR) by liver
s a substrate. Mitochondria were incubated without PMSF (CONT), or with 75 mM,
led state (after FCCP) are comparable under all conditions. (d) As above, using the
ces to colour in this figure legend, the reader is referred to the web version of this
Fig. 3. PMSF addition enables quantitative measurement of mitochondrial H2O2 release by AR. (a) H2O2 release from purified liver mitochondria measured by the HRP method and
PMSFmethod in parallel experiments. Mitochondriawere prepared from 3 young (8months, ‘Y’) and 3 old (30months, ‘O’) mice and the experiments were carried out in 4 conditions as
follows: pyruvateþmalate (PM), pyruvateþmalateþrotenone (PMþRot), succinate (suc) and succinate and rotenone (sucþRot). The slope of the regression and the intercept are not
significantly different from one or zero, respectively. (b) Representative traces from parallel experiments conducted with either AR plus PMSF (AR, left) or Homovanillic acid (HVA, right)
on purified liver mitochondria with succinate (4 mM, Suc) as substrate, followed by rotenone (2.5 mM, Rot). Symbols denote the following conditions: liver mitochondria in the presence
(diamonds) or absence (circles) of 100 mMPMSF. Ethanol (EtOH) was added as a control; closed symbols indicate presence of HRP in the reactionwhile open symbols indicate no HRP. (c)
Average H2O2 release rates from succinate-energized liver mitochondria with or without rotenone measured with either AR plus PMSF (filled bars) or HVA (open bars). Data are
mean7SD from 3 independent experiments. * denotes po0.05. (d) Same as (b), but with brainmitochondria. (e) Same as (c), but with brainmitochondria. (f) H2O2 release rates by liver,
brain and muscle mitochondria respiring complex I linked substrate (5 mM pyruvate þ malate, PM) in the presence of 100 μM PMSF. Representative kinetic traces are shown in state 1
(no substrate), state 2 (after PM) and after blocking the electron flow at complex I by rotenone (2.5 mM, Rot). (g) Quantification of (f). Data are mean7SD from 3 technical repeats. (h)
Same as (f), but with complex II-linked substrate (4 mM succinate, Suc). (i) Quantification of h. Data are mean7SD from 3 technical repeats.
Fig. 4. Measurement of H2O2 release from cultured cells. Cells from the indicated strains were incubated with AR in the absence (a) or presence (b) of HRP and either no
further addition (initial), 100 mM PMSF, or 100 mM PMSF plus 50 U/ml catalase (CAT). Data are mean7SD from 3 experimental replicates. Asterisks indicate significant
differences (***po0.001) between PMSF and initial and between PMSFþCAT and PMSF (cell line-specific ANOVA followed by Holm–Sidak post-hoc test).
S. Miwa et al. / Free Radical Biology and Medicine 90 (2016) 173–183178independent conversion of AR by liver mitochondria was not
mediated by H2O2 release. To assess whether PMSF might impact
on mitochondrial function, we measured oxygen consumption
rates (OCR) of liver mitochondria treated with different con-
centrations of PMSF in states 2, 3, 4 and after complete uncoupling
using FCCP (Fig. 2c and d). Even at a PMSF concentration 5 times
higher than that used for the AR experiments, OCR was unchanged
under all conditions, showing that PMSF did not have adverse
effects on electron transport chain activity. Together, these data
suggest that PMSF inhibited the enzyme(s) responsible for the
HRP-independent conversion of AR to resorufin, while leaving the
capacity for HRP-dependent AR oxidation by H2O2 intact.
We realized that HRP-dependent AR oxidation rates (in the
absence of PMSF, calculated as the difference between the rates
with and without HRP) in liver mitochondria should represent AR
oxidation rates measured from PMSF treated mitochondria in the
presence of HRP, that is the AR oxidation specific to mitochondrial
H2O2 release: in fact they were very similar (see Fig. 2a). To test
this further, we compared the results from both approaches over a
range of H2O2 release rates by liver mitochondria from both young
and old animals, by varying experimental conditions using com-
plex I and II linked substrates, and with and without rotenone.
Over one order of magnitude difference in H2O2 release rates, the
results from both methods were in excellent agreement (Fig. 3a).
Moreover, we quantitatively compared H2O2 release rates by
PMSF-treated liver mitochondria as measured using AR with an
alternative method, using Homovanillic acid (HVA). HVA is an-
other commonly used HRP-dependent fluorescent probe to
monitor H2O2 generation. With this probe, there was no HRP-in-
dependent HVA oxidation in liver mitochondria (Fig. 3b). H2O2
release rates with succinate as substrate determined using HVA
were comparable to those of PMSF-treated mitochondria mea-
sured using AR (Fig. 3b and c). Slowing down the rate of H2O2
release by addition of rotenone was seen by both methods, but the
rates measured using the HVA method were lower than those
measured using the AR method (Fig. 3c). Brain mitochondria
yielded similar results (Fig. 3d and e), showing a discrepancy be-
tween the two methods when H2O2 release rates are low. This is
most probably due to the known lower sensitivity and thus a
higher detection limit of the HVA assay [32]. In agreement with
that, we could not detect H2O2 release by brain mitochondria re-
spiring complex I linked substrate with the HVA assay unless ro-
tenone was present, although it was clearly detectable by AR
(Supplementary Figure S2). Taken together, the data indicate that
in the presence of PMSF the AR methods enables for the first time
realistic estimates of H2O2 release from mitochondria in differenttissues including liver (Fig. 3f–i).
Frequently, the AR method is used to measure hydrogen per-
oxide release from cultured cells. We measured resorufin fluor-
escence generated with and without HRP, PMSF and catalase
(Fig. 4a and b) from four cell lines: AML12 mouse hepatocytes;
MRC5, a primary human fibroblast strain; C2C12 undifferentiated
mouse myoblasts; and Hep G2 human hepatocellular carcinoma
cells. All four lines showed significant HRP-independent resorufin
production that was completely inhibited by PMSF (Fig. 4a). HRP-
dependent, PMSF-insensitive resorufin production was sensitive to
catalase (Fig. 4b), indicating that this was a correct indication of
H2O2 release. It should be noted that the cell lines rank differently
in terms of PMSF-dependent and –independent resorufin pro-
duction rate in accordance with primary fibroblasts being more
dependent on oxidative phosphorylation (and thus producing
more H2O2) than immortalized and tumour cells.
3.3. AR crosses the mitochondrial membrane and is converted to
resorufin in the matrix
To identify the source of the HRP-independent AR conversion
to resorufin by liver mitochondria, we first assessed the possibility
of microsomal contamination. However, our mitochondrial pre-
parations were pure; fewer than 5% of the total of the 4600 de-
tected proteins in purified liver mitochondria were of microsomal
origin [24]. Moreover, confocal imaging of purified liver mi-
tochondrial preparations showed resorufin fluorescence only in
organelles which were also positive for the mitochondrial marker
Mitotracker green (Fig. 5a), thus excluding non-mitochondrial or-
ganelles as sites of HRP-independent resorufin generation. Profile
scanning of the confocal mitochondrial images revealed a wider
signal for Mitotracker Green, while the resorufin fluorescence was
focussed closer to the centre of the mitochondrial images (Fig. 5b),
suggesting an intramitochondrial origin of the resorufin
fluorescence.
In order to determine the submitochondrial localisation of the
site of AR conversion to resorufin, mitoplasts (mitochondria
without the outer membrane), ‘shaved’ mitoplasts (mitoplasts
after removal of intermembrane space proteins), and inner mi-
tochondrial membranes were prepared from purified liver mi-
tochondria (Fig. 5c). All three fractions were tested for PMSF-
sensitive AR conversion to resorufin. As seen in Fig. 5d, HRP-in-
dependent, PMSF-sensitive AR conversion to resorufin occurred in
intact mitochondria and in shaved and unshaved mitoplasts, but
not in the inner membrane fraction. These observations were
supported by confocal imaging, showing a clear resorufin
Fig. 5. PMSF-sensitive conversion of AR to resorufin occurs in the mitochondrial matrix. (a) Confocal images of isolated liver mitochondria (average intensity projections of
100.1 μM confocal planes captured at 1 Airy unit) showing resorufin and Mitotracker Green fluorescence. Resorufin fluorescence can be seen throughout the mitochondria
matrix. Scale bar is 5 mM. (b) Mean line profile intensities of resorufin (RR) fluorescence through the central plane image of intact mitochondria after normalising both
intensity (maxima¼1) and size (edges and centre defined to set all objects to an equal, arbitrary diameter). N¼13. Full width half maximum of the resorufin distribution is
smaller than that of Mitotracker Green (MTG, po0.001, paired t test). (c) Western blots of mitochondrial subfraction marker proteins. AIF, apoptosis inducing factor;
NDUFA9, NADH dehydrogenase 1 alpha subcomplex 9 (a component of complex I in the inner membrane); GDH, glutamate dehydrogenase. (d) Representative traces of
resorufin fluorescence following incubation of the indicated liver mitochondrial subfraction with AR in the absence of HRP or substrate. All reactions are PMSF sensitive. (e)
Resorufin fluorescence measured after incubation of intact liver mitochondria with AR for 10 min. Fluorescence (no PMSF, no further AR) was measured from intact
mitochondria (ARþmt) and after removing the outer membrane and intermembrane space (ARþshaved mtp). Controls were mitochondria incubated without AR (mt) and
blanks. Data are mean7SD, n¼3. (f) Representative traces of resorufin fluorescence in assay medium containing AR-pre-incubated liver (red circle) or brain (blue circle)
mitochondria as only source of AR. Liver mitochondria were pre-treated (red diamonds) or not (red circle) with PMSF. 50mM AR without mitochondria was used as positive
control. 49 pmole H2O2 were added at the indicated time point. (g) Quantification of the experiment in f. Data are mean7SD, n¼4. All values are significantly above 0
(Po0.05, t-test). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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ments showed that the PMSF-sensitive conversion of AR did not
occur on the outside of the inner mitochondrial membrane (be-
cause the inner membrane fraction was negative) or in the intra-
membrane space (because rates were equal for mitoplasts and
shaved mitoplasts, Fig. 5d). This suggested that AR is able to cross
the inner mitochondrial membrane and that the AR-converting
activity resided in the matrix. To see whether AR was also able to
cross the outer membrane, we incubated liver mitochondria with
AR for 10 min without PMSF, allowing for its conversion to re-
sorufin, and divided them into two aliquots. Then the outer
membrane from one aliquot of mitochondria was removed and the
other served as a control. The resorufin fluorescence intensity of
the mitochondria without the outer mitochondrial membrane was
identical to the rest of mitochondria (Fig. 5e), confirming that the
resorufin signal was not associated with the outer membrane.
To see whether AR can cross mitochondrial membranes in both
directions, liver and brain mitochondria were incubated with AR
for 10 min at 37 °C, washed twice and then incubated in fresh
assay mediumwith HRP but not AR. External H2O2 (49 pmole) was
then added. In this setting, mitochondria are the only source of AR.
Only if the washed mitochondria retain AR and release it into the
assay medium, can resorufin be generated by HRP-catalysed oxi-
dation by H2O2. This happened for both brain and liver mi-
tochondria (Fig. 5f), albeit the latter displayed a higher basal level
of fluorescence and a lower level of resorufin formation followingH2O2 addition, suggesting that a significant proportion of AR had
already been converted to resorufin in liver mitochondria prior to
the HRP-dependent H2O2 assay. This was confirmed if liver mi-
tochondria were pre-treated with PMSF, leading to low basal
fluorescence and more pronounced H2O2-induced resorufin for-
mation similar to brain mitochondria (Fig. 5f). Quantification of
the resultant resorufin suggested that the amount of retained AR
limited H2O2 detection (Fig. 5g). Conversely, when mitochondria
were pre-incubated with HRP instead of AR, and washed prior to
adding AR (but not HRP) for an H2O2 assay, no conversion of AR to
resorufin was observed (data not shown), confirming that AR but
not HRP was able to permeate the mitochondrial membrane. To-
gether, these data indicate that AR can transverse the mitochon-
drial membrane in both directions (either by diffusion or by a
transporter-mediated mechanism).
3.4. Carboxylesterase catalyses the HRP-independent conversion of
AR to resorufin
To identify enzymes that could perform the HRP-independent,
PMSF-inhibitable conversion of AR to resorufin, we searched lists
of proteins specific to highly purified mouse liver mitochondria
[24,33]. This suggested carboxylesterases (CESs) as possible can-
didates: CESs belong to the serine hydrolase family [34,35], and
PMSF targets serine residue in the active site of enzymes [30].
PMSF was reported to inhibit carboxylesterases [36], and other
Fig. 6. Carboxylesterase catalyses the HRP-independent conversion of AR to resorufin. (a) Representative traces of resorufin fluorescence catalyserd by the indicated tissues
without addition of HRP. 100 μM PMSF was added at the indicated time point. (b) Rates of HRP-independent resorufin generation by the indicated tissues. Data are
mean7SD from 2 to 4 independent experiments. In a lower panel, each tissue homogenate sample (30 mg protein) was tested for CES1 abundance by Western blot. (c)
Detection of CES1 by Western blot in pure liver mitochondria (1), mitoplasts (2), shaved mitoplasts (3), but not in inner membrane subfractions (4), suggesting it is in the
mitochondrial matrix. (d) Human recombinant Carboxylesterase 1 isoform b (Ces1b) converts AR to resorufin in a PMSF-sensitive manner. 100 μM PMSF was added at the
indicated time point. (e) PMSF dose response curves for the AR conversion to resorufin by Ces1b (Ces1b, black circle) and liver mitochondria (Liver mito, red circle). (f)
Michaelis–Menten kinetics showing the rate of resorufin production (in pmol/min) by recombinant Ces1b vs AR concentration. (For interpretation of the references to colour
in this figure legend, the reader is referred to the web version of this article.)
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20 isoforms of CES in the mouse with tissue specific distributions
[38], participating in the metabolism of xenobiotics, drugs and
lipids. Different CES isoforms CES1, CES3, CES5 and CES6 have been
found in highly purified mouse liver mitochondria [24,33]. The
CES1 gene structure suggests a 50–60% probability for mitochon-
drial localisation [39].
Different tissues catalyse the HRP-independent conversion of
AR to resorufin at different rates, however, all are inhibited by
PMSF (Fig. 6a). The tissue distribution of CES1 corresponds well
with the PMSF-inhibitable production of resorufin (Fig. 6b). Dis-
crepancies in individual tissues (e.g., gut and lung) might be due to
cross-reactivities and/or different isoforms being expressed.
Within liver mitochondria, CES1 is located in the matrix (Fig. 6c),
as is the HRP-independent AR conversion to resorufin (see Fig. 5d).
Finally, human Carboxylesterase 1 isoform b (Ces1b) converts
AR to resorufin in the absence of H2O2 and HRP in vitro (Fig. 6d).
The reaction is inhibited by PMSF with an IC50 ∼5 mM, exhibiting
similar behaviour to liver mitochondria (Fig. 6e). This reaction
follows Michaelis–Menten kinetics, yielding a Vmax of
11.070.7 pmol/min and a KM of 55712 mM at 12.5 U/ml, in-
dicating that CES behaved like a typical enzyme with AR as a
substrate (Fig. 6f). Following its incubation with CES for 28 h, up to
90% of the original AR molecules in the reaction were detected as
resorufin (Supplementary Figure S3). The UV spectrum of the re-
action product was identical to that of resorufin (not shown) andthe identity of the product was confirmed by LCMSMS (Supple-
mentary Figure S4). The reaction of AR and Ces1b was sensitive to
a typical inhibitor for CES1 and CES2, bis(4-nitrophenyl)phosphate
(BNPP), resulting in 80–90% inhibition at 1 mM, IC50 ∼0.15 mM si-
milar to that of liver mitochondria (Supplementary Figure S5a).
Importantly, like PMSF, BNPP at concentrations that inhibited CES
efficiently did not impact on mitochondrial respiration (Supple-
mentary Figure S5b), and conversion of AR to resorufin in the
presence of BNPP required HRP (Supplementary Figure S5c). Lo-
peramide (LPM) is known as a specific inhibitor for CES2, and CES1
has been shown to be insensitive to LPM over a range of con-
centrations (up to 100 mM) when classic CES substrates were used,
such as 4-Nitrophenyl acetate, Fluorescein diacetate [40] or p-ni-
trophenyl acetate [41]. However, both the Ces1b- catalysed con-
version of AR to resorufin in vitro and the conversion catalysed by
liver mitochondria showed similar behaviour in the presence of
LPM, with only ∼50% inhibition of activity observed in the pre-
sence of 100 mM LPM (Supplementary Figure S6). These data
suggest that CES1, and possibly CES2, can account for AR conver-
sion activity.
To understand the potential reactions between carbox-
ylesterases and AR, we performed docking simulations based on
the resolved structure of CES1 in complex with a heroin analogue
(PDB Id: 1MX9) and the published homology model of CES2
[27,42]. Simulating the putative complex of AR within the enzy-
matic cavity of CES1 (Fig. 7a) showed significant complex-
Fig. 7. CES1 and CES2 can interact with AR. (a) Docking simulation on CES 1 and (b)
on CES2 2 for AR. The substrate is shown as balls and sticks with the interacting
residues in liquorice. Green colour indicates carbon, blue indicates nitrogen, red
stands for oxygen and yellow for sulphur atoms. For clarity reasons, the hydrogen
atoms are not displayed. (c) Proposed mechanism for CES to convert AR to resor-
ufin. (For interpretation of the references to colour in this figure legend, the reader
is referred to the web version of this article.)
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a position conducive to catalysis: Its carbonyl carbon atom ap-
proached the hydroxyl group of Ser221, while the carbonyl oxygen
atom clearly forms H-bonds with the so-called oxyanion hole that
is composed of the backbone atoms of Gly142 and Gly143. Theremaining part of the substrate is substantially engaged in hy-
drophobic contacts. In detail, the phenoxazine ring stabilizes π–π
stacking interactions with Phe101, Phe365, Phe426, and His 468,
plus hydrophobic contacts involving several apolar side-chains
surrounding the AR molecule (e.g. Val254, Leu255, Leu318, Ile359,
Ile388 and Met425). Notably, Leu255 and Ala222 also contact the
methyl group of the acetyl moiety. In contrast, the two hydroxyl
functions were involved in not more than weak H-bonds with
backbone atoms (e.g. the 3-hydroxyl approaches the backbone
carbonyl group of His468). Together, the molecular docking si-
mulations confirmed the overall stability of the computed com-
plex and revealed the key role played by Van der Waals and hy-
drophobic interactions in both complex stabilization and un-
docking processes [43].
Fig. 7b shows the putative complex between AR and CES2.
Again, the hydrolysable group of the substrate is placed in a po-
sition suitable for catalytic interaction since its carbonyl carbon
atom conveniently approaches the key catalytic Ser228 residue.
The CES2 subpocket accommodating the phenoxazine ring in-
cludes some polar residues and indeed the two hydroxyl functions
are engaged in H-bonds with Ser233 and Ser254 while the phe-
noxazine ring elicits hydrophobic contacts involving Leu151,
Leu179, Ile251, and Leu461. The comparison of the two putative
complexes reveals some relevant differences mostly focused on
the contacts stabilized by the phenoxazine ring. Both enzymes
elicit rich networks of hydrophobic contacts which are reinforced
by π–π stacking in CES1 and by H-bonds with hydroxyl functions
in CES2.
Using these models together with published correlative data
[42] , pKm values were predicted for the interactions of either
CES1 or CES2 with AR (Supplementary Table S1), resulting in ex-
cellent agreement with the experimentally measured CES1 pKm
value.
The low distances between the labile group of AR and the
catalytic serine residues of either CES1 or CES2 (Supplementary
Table S1) indicate AR as a possible catalytic substrate for both
enzymes. Thus, we propose that CES1 and CES2 are able to convert
AR to resorufin in a two-step reaction (Fig. 7c). Enzymatic data and
docking simulations suggest that CES1 and CES2 act as amidases,
cleaving the amide group of AR, resulting in the release of acetic
acid and 3,7-dihydroxyphenoxazine (dihydroresorufin). While we
cannot predict how the spontaneous oxidation of 3,7-dihydrox-
yphenoxazine might occur in physiological conditions, we argue
that 3,7-dihydroxyphenoxazine is significantly more reactive than
AR or resorufin according to its computed quantum-chemical de-
scriptors (Supplementary Table S2). In the presence of molecular
oxygen, 3,7-dihydroxyphenoxazine is readily oxidised to resorufin,
forming the basis of the ‘Vanishing Valentine’ classroom experi-
ment [44]. However, the in vitro conversion of AR to resorufin was
observed to be as efficient in an anaerobic chamber (oxygen
concentration o5 ppm) using degassed water as it was in air
(Supplementary Fig. S7a), and the reaction was not inhibited by
catalase (Supplementary Fig. S7b). In oxygenated solution in
complete darkness, the oxygen consumption detected by high-
resolution oxygraphy was very low and not different whether re-
sorufin was produced or not (by blocking the reaction with PMSF)
(Supplementary Fig. 7c–e), suggesting that the observed slope of
the oxygraph trace was due to electrode drift. In any case, this
slope would only equate to less than 0.0002 moles oxygen con-
sumed per mole resorufin formed. While the mechanism of 3,7-
dihydroxyphenoxazine oxidation during the CES-catalysed reac-
tion remains unresolved, the oxidation step is unlikely to be rate-
limiting.
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The two main results of our study, namely that mitochondrial
membranes are permeable to AR and that carboxylesterases can
convert AR to resorufin in a HRP- and oxygen-independent reac-
tion that is inhibited by PMSF, bear a number of interesting con-
sequences. First, they enable the sensitive and quantitative assay
of H2O2 release by mitochondria from tissues, cells and mi-
tochondria with high CES content such as liver using the AR
method. We showed here that the PMSF-insensitive and the HRP-
dependent part of the resorufin fluorescence were quantitative
measures of H2O2. PMSF could be substituted by BNPP, as both did
not affect OCR, and resorufin formation in the presence of either
PMSF or BNPP was fully dependent on HRP, suggesting it was due
to HRP-catalysed oxidation by H2O2.
It had previously been claimed that liver mitochondria pro-
duced more ROS than mitochondria from other tissues under
comparable experimental conditions[15,19–21] and that liver mi-
tochondria ROS production was insensitive to variations in sub-
strates and ETC inhibitors [45–47]. These are most probably mis-
interpretations due to the observed high CES activity, which masks
the real H2O2-dependent signals. Our results indicated qualita-
tively and quantitatively similar H2O2 release rates in mitochon-
dria from liver and other tissues (see Fig. 3f–i). Our data revealed
for the first time tissue-specific differences in the characteristics of
complex I-linked H2O2 release. For example, liver mitochondria
are much less sensitive to rotenone in forward-electron flow H2O2
release (i.e. when complex I substrate was used) compared with
brain or muscle mitochondria, whereas they are equally sensitive
to reverse flow mediated H2O2 release (i.e. ∼50% reduction in the
rate of H2O2 release when complex II linked substrate was used).
We verified that membranes of intact mitochondria are
permeable to AR, but not to HRP. Therefore, the notion that the AR
method quantitatively detects extramitochondrial release of H2O2
still holds, as long as inhibitors of HRP-independent AR conversion
are added to the experiments.
Second, our data provide a rationale for a novel carboxylesterase
assay by measuring the PMSF-sensitive and HRP-independent con-
version of AR to resorufin. In vitro, CES converts AR quantitatively to
resorufin, following strict Michaelis–Menten kinetics (Fig. 6f). In li-
ver mitochondria ex vivo, this conversion of AR to resorufin changes
with the physiological state of the tissue, for instance, it increases
with donor age and decreases under dietary restriction (Supple-
mentary Figure S8). However, exactly which isoforms of CES are
involved in this reaction in different tissues is unknown.
Finally, our data support the speculation that mitochondria could
function as sites of xenobiotic drug metabolism. If AR crosses mi-
tochondrial membranes other molecules may have the same ability.
Enzymatic reactions involving CES will frequently produce free ra-
dical species, either directly or indirectly. A localisation of carbox-
ylesterases in the mitochondrial matrix with its high concentration
of antioxidants might therefore be advantageous for the cell.Acknowledgements
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